FDAnews
www.fdanews.com/articles/122878-oncothyreon-initiates-phase-iii-trial-of-stimuvax-in-asian-patients-with-nsclc

Oncothyreon Initiates Phase III Trial of Stimuvax in Asian Patients With NSCLC

December 10, 2009
Oncothyreon Inc. Thursday announced that Merck KGaA of Darmstadt, Germany, has initiated a Phase 3 trial of Stimuvax (BLP25 liposome vaccine) in Asian patients with advanced non-small cell lung cancer (NSCLC).
SunHerald